Patrick Günther

Patrick Günther

Auto-generated profile, based on publicly available information

Patrick Günther

Genomics and Immunoregulation, Life & Medical Sciences (LIMES) Institute, University of Bonn

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Cell
Verified
Journal Article
Closed access
ACAnette Christ
Anette Christ
PGPatrick Günther
Patrick Günther
MLMario A.R. Lauterbach
Mario A.R. Lauterbach
PDPeter Duewell
Peter Duewell
DBDebjani Biswas
Debjani Biswas
ELEicke Latz
Eicke Latz

9 September 2016 in Science
Verified
Journal Article
Closed access
PDF file
EMElvira Mass
Elvira Mass
IBIvan Ballesteros
Ivan Ballesteros
MFMatthias Farlik
Matthias Farlik
FHFlorian Halbritter
Florian Halbritter
PGPatrick Günther
Patrick Günther
FGFrederic Geissmann
Frederic Geissmann
INTRODUCTION: Embryonic development and tissue homeostasis depend on cooperation between specialized cell types. Resident macrophages are professional phagocytes that survey their surroundings; eliminate unfit cells, microorganisms, and metabolic waste; and produce a large range of bioactive molecules and growth factors. Resident macrophages also serve tissue-specific purposes: For example, microglia in the central nervous system support neuronal circuit development, Kupffer cells scavenge blood particles and dying red blood cells in the liver, and alveolar macrophages uptake surfactant and remove airborne pollutants and microbes from the airways. Resident macrophage diversity in adult mice is reflected in tissue-specific gene expression profiles, which may be due to responses to specific cues from their microenvironment, different developmental processes, and the contribution of distinct progenitors cell types. Altogether, the mechanisms responsible for the generation of tissue-resident macrophage diversity remain unclear.RATIONALE: Tissue-resident macrophages originate, at least in part, from mesodermal erythro-myeloid progenitors (EMPs) from the yolk sac, which invade the embryo proper at the onset of organogenesis. These tissue-resident macrophages are also self-maintained in postnatal tissues, independently of definitive hematopoietic stem cells (HSCs) in a steady state. We therefore hypothesized that resident macrophages represent a founding cell type within most organanlagen. In this model, the generation of macrophage diversity, as observed in the tissues of postnatal mice, may be integral to organogenesis.RESULTS: To test this hypothesis and explore the molecular basis of macrophage diversity in mammals, we performed a spatiotemporal analysis of macrophage development in mice, from embryonic day 9 (E9) to 3 weeks after birth. Unbiased single-cell RNA sequencing (RNA-seq) analysis of CD45+cells, combined with RNA-seq analyses of sorted cell populations, genetic fate mapping, and in situ analyses, revealed that EMPs give rise to a population of premacrophages (pMacs) that colonize the whole embryo from E9.5, as they acquire a core macrophage differentiation program that includes pattern recognition, scavengers, and cytokine receptors. The chemokine receptorCx3cr1is up-regulated in pMacs and is important for embryo colonization, which is delayed inCx3cr1-deficient embryos. Fate mapping of pMacs using aTnfrsf11a–Cre reporter labels homogeneously fetal and adult tissue-resident macrophages but not HSCs and their progeny. Transcriptional regulators that identify postnatal tissue-resident macrophages in the brain, liver, kidney, skin, and lung were specifically up-regulated immediately after colonization. These dynamic changes mark the onset of diversification into adult macrophages. We identifiedId3as a Kupffer cell–specific transcriptional regulator. Deletion ofId3in pMacs resulted in Kupffer cell deficiency but did not affect development of microglia and kidney macrophages.CONCLUSION: Our study shows that EMP-derived precursors colonize embryonic tissues and simultaneously acquire a full core macrophage program. This is followed by their diversification into tissue-specific macrophages during organogenesis, likely via the expression of distinct sets of transcriptional regulators. These results indicate that differentiation of tissue-resident macrophages is an integral part of organogenesis and identify a spatiotemporal molecular road map for the generation of macrophage diversity in vivo. Our findings provide a conceptual framework to analyze and understand the consequence(s) of genetic variation for macrophage contribution to development, homeostasis, and disease pathogenesis in different tissues and will support efforts to differentiate specialized macrophages in vitro.

9 June 2017 in Science
Verified
Journal Article
Closed access
PDF file
PSPeter See
Peter See
CDCharles-Antoine Dutertre
Charles-Antoine Dutertre
JCJinmiao Chen
Jinmiao Chen
PGPatrick Günther
Patrick Günther
NMNaomi McGovern
Naomi McGovern
FGFlorent Ginhoux
Florent Ginhoux
Tracing development of the dendritic cell lineage: Dendritic cells (DCs) are important components of the immune system that form from the bone marrow into two major cell lineages: plasmacytoid DCs and conventional DCs. Seeet al.applied single-cell RNA sequencing and cytometry by time-of-flight to characterize the developmental pathways of these cells. They identified blood DC precursors that shared surface markers with plasmacytoid DCs but that were functionally distinct. This unsuspected level of complexity in pre-DC populations reveals additional cell types and refines understanding of known cell types.Science, this issue p.eaag3009

20 November 2015 in Science
Verified
Journal Article
Closed access
PDF file
EVErika Vacchelli
Erika Vacchelli
YMYuting Ma
Yuting Ma
EBElisa E. Baracco
Elisa E. Baracco
Antonella SistiguAntonella Sistigu
Antonella Sistigu
DEDavid P. Enot
David P. Enot
Guido KroemerGuido Kroemer
Guido Kroemer
How dying tumor cells get noticed: Besides killing tumor cells directly, some chemotherapies, such as anthracyclines, also activate the immune system to kill tumors. Vacchelli et al. discovered that in mice, anthracycline-induced antitumor immunity requires immune cells to express the protein formyl peptide receptor 1 (FPR1). Dendritic cells (DCs) near tumors expressed especially high amounts of FPR1. DCs normally capture fragments of dying tumor cells and use them to activate nearby T cells to kill tumors, but DCs lacking FPR1 failed to do this effectively. Individuals with breast or colon cancer expressing a variant of FPR1 and treated with anthracyclines showed poor metastasis-free and overall survival. Thus, FPR1 may affect anti-tumor immunity in people, too. Science , this issue p. 972

1 December 2019 in Cell Metabolism
Verified
Journal Article
Closed access
CCChristina D. Camell
Christina D. Camell
PGPatrick Günther
Patrick Günther
ALAileen Lee
Aileen Lee
EGEmily L. Goldberg
Emily L. Goldberg
OSOlga Spadaro
Olga Spadaro
VDVishwa Deep Dixit
Vishwa Deep Dixit

1 December 2017 in Immunity
Verified
Journal Article
Open access
JSJil Sander
Jil Sander
SSSusanne V. Schmidt
Susanne V. Schmidt
BCBranko Cirovic
Branko Cirovic
NMNaomi McGovern
Naomi McGovern
OPOlympia Papantonopoulou
Olympia Papantonopoulou
JSJoachim L. Schultze
Joachim L. Schultze
Human in vitro generated monocyte-derived dendritic cells (moDCs) and macrophages are used clinically, e.g., to induce immunity against cancer. However, their physiological counterparts, ontogeny, transcriptional regulation, and heterogeneity remains largely unknown, hampering their clinical use. High-dimensional techniques were used to elucidate transcriptional, phenotypic, and functional differences between human in vivo and in vitro generated mononuclear phagocytes to facilitate their full potential in the clinic. We demonstrate that monocytes differentiated by macrophage colony-stimulating factor (M-CSF) or granulocyte macrophage colony-stimulating factor (GM-CSF) resembled in vivo inflammatory macrophages, while moDCs resembled in vivo inflammatory DCs. Moreover, differentiated monocytes presented with profound transcriptomic, phenotypic, and functional differences. Monocytes integrated GM-CSF and IL-4 stimulation combinatorically and temporally, resulting in a mode- and time-dependent differentiation relying on NCOR2. Finally, moDCs are phenotypically heterogeneous and therefore necessitate the use of high-dimensional phenotyping to open new possibilities for better clinical tailoring of these cellular therapies.